- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02641275
Self-management Training for Parents With Chronic Muscular Dystrophia (ZRM-CMD-P)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background:
The relentless progressive process of muscular dystrophy requires extraordinary medical, physical, and emotional care. As a consequences caring for a patient with a severe chronic illness has been associated with increased stress and diminished social, psychological and physical well-being in parents. According to Thompson et al. 57% of parents with Duchenne muscular dystrophy children have self-reported poor psychological adjustment and, even in comparison with parents of children with other burdens like cerebral palsy or renal diseases, muscular dystrophy was associated with a wider spectrum of problems and parental stress. Moreover, parents are shown to have significant stress by feelings of guilt and associated difficulty discussing death issues with their children.
However, despite the obvious need of support for parents only few and weak data exist regarding efficiency and efficacy of specific interventions supporting parental resilience and coping strategies. In practice, they are mostly limited to meetings of self-help groups and casual exchange between concerned parents, which is rather a problem-centered than proactive solution-focused approach. As a consequence, investigators see a great need for studies regarding more specific interventions supporting parents' self-management skills, coping strategies and competencies.
Objectives:
The present study evaluates the efficacy of a structured self-management training for parents of children with severe progressive muscular dystrophy compared to parents receiving treatment as usual (TAU). In addition, investigators measure established biomarkers of psychosocial stress, such as pro-inflammatory cytokines, which will be used to monitor physiological changes with assumed significance for parental health.
Methods:
Participants will fill out online-questionnaires before, during and after self-management training. Training interventions will take place in Zurich as group sessions (10-20 participants per group). Investigators aim for a total of 60-80 participants. Parent-couples or single participants will be randomized in an intervention group (participants receiving self-management training) and a non-intervention group (participants continue with already established support). After one year parents from the non-intervention group will change into the intervention group with self- management training as well. Questionnaires focus on assessing parental strain and self- efficacy and will take 30-45minutes for each of four surveys. Validated biological markers such as cumulative cortisol levels in hair and pro-inflammatory cytokines in the blood will be collected before and after self-management trainings.
Study Type
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Parents with at least one living child affected by chronic muscular dystrophy
Exclusion Criteria:
- Dying of a child during intervention and analysis.
- Severe/significant psychological disorder (in case of existing psychological support, participation should be agreed/supported by therapist, too)
- Recent or concomitant self-management training
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention
Structured self-management-training (incl.
systemic analysis, coaching, teaching) in 4 sessions.
|
Structured self-management-training (incl.
systemic analysis, coaching, teaching) in 4 sessions
|
No Intervention: Control group
no intervention other than existing support (see exclusion criteria).
However, intervention will be offered and studied secondary as well (after 1 1/2 year of no intervention).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Action Orientation Questionnaire (HAKEMP)
Time Frame: 1 1/2 year with control group
|
Kuhl and co-workers introduced a special questionnaire (HAKEMP) to assess the tendency of people in concrete situations to revert to an action-oriented or state-oriented condition in 24 items.
|
1 1/2 year with control group
|
Self-efficacy: Thought control of action (SWE)
Time Frame: 1 1/2 year with control group
|
Quantify improved parental resilience and coping strategies facing chronic stress.
Questionnaire developed by Jerusalem and Schwarzer, 1981, revised 1999 to test general self-efficacy in 10 items.
|
1 1/2 year with control group
|
Change in Experiencing and Behaviour post-intervention (VEV)
Time Frame: 1 1/2 year with control group
|
VEV is a questionnaire developed by Ziele and Kopf-Mehnert, 1978 to test post-intervention change in experiencing and behavior along with a retrospective life-event checklist and a self-rating questionnaire in 42 items.
Other than previous questionnaires VEV will be applied only after intervention.
|
1 1/2 year with control group
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants With Sum of Abnormal Laboratory Values Concerning Biomarkers of psychosocial stress
Time Frame: 1 1/2 year with control group
|
Significant lower levels of biomarkers of psychosocial stress, i.e. pro-inflammatory cytokines, which can be used to monitor physiological changes with assumed significance for parental health: C-reactive Protein (hsCRP), Tumor-Necrose-Factor alpha (TNFα), Interleukin (IL)-1ß, IL-6, und Interferon Gamma (IFNγ).
Items will be aggregated as a numerical factor which shows the difference of a measured value from a reference value .
Abnormal laboratory values therefore will be used as a sum.
|
1 1/2 year with control group
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Jürg C Streuli, MD PhD, University Children's Hospital, Zurich
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ZRM-CMD Parents
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Muscular Dystrophies
-
Assistance Publique - Hôpitaux de ParisRecruitingLimb Girdle Muscular DystrophiesFrance
-
aTyr Pharma, Inc.CompletedLimb-Girdle Muscular Dystrophies | Facioscapulohumeral Muscular DystrophyUnited States, Denmark, France
-
Wake Forest University Health SciencesMuscular Dystrophy AssociationCompletedMuscular Dystrophies, Limb-Girdle (GENETICALLY CONFIRMED)United States
-
Virginia Commonwealth UniversityWashington University School of Medicine; University of Iowa; University of Minnesota and other collaboratorsRecruitingMuscular Dystrophies | Limb Girdle Muscular DystrophyUnited States, United Kingdom
-
Sarepta Therapeutics, Inc.Active, not recruiting
-
ML Bio Solutions, Inc.Virginia Commonwealth UniversityCompletedMuscular Dystrophies | Limb Girdle Muscular DystrophyUnited States, Denmark
-
Neurogen Brain and Spine InstituteWithdrawn
-
Rigshospitalet, DenmarkRecruitingLimb Girdle Muscular DystrophyDenmark
-
Rigshospitalet, DenmarkFunding: Toyota Foundation; Funding: Hede Nielsen Foundation; Funding: Grosserer... and other collaboratorsActive, not recruiting
-
GenethonActive, not recruitingLGMD2IDenmark, France, United Kingdom
Clinical Trials on Structured self-management-training
-
Fundacio d'Investigacio en Atencio Primaria Jordi...Institut Catala de SalutUnknownChronic Obstructive Pulmonary DiseaseSpain
-
Northwestern UniversityCompletedMelanomaUnited States
-
Saglik Bilimleri UniversitesiCompleted
-
University of ArizonaNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedOsteoarthritisUnited States
-
University of South FloridaNational Cancer Institute (NCI)CompletedCancer | Unspecified Adult Solid Tumor, Protocol Specific | Psychological StressUnited States, Puerto Rico
-
T.C. ORDU ÜNİVERSİTESİInonu UniversityCompletedPulmonary Disease, Chronic Obstructive | Dyspnea | Health-Related Quality Of LifeTurkey
-
University of PennsylvaniaNational Cancer Institute (NCI)Active, not recruitingQuality of Life | Ostomy | TelehealthUnited States
-
University of PennsylvaniaYale University; City of Hope Medical Center; University of ArizonaCompleted
-
University of FloridaNot yet recruiting
-
Rush University Medical CenterAmerican Lung AssociationCompleted